PFIZER INC. (LON:PFZ) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On March 5, 2018, the Board of Directors of Pfizer Inc. (the “Company”) elected Dr. Dan R. Littman to serve as a member of the Company’s Board of Directors, effective immediately. In addition, he was appointed to the Corporate Governance Committee and the Science and Technology Committee of the Board.
Dr. Littman has been provided an indemnification agreement and will receive compensation in accordance with the Company’s standard arrangements for non-employee directors.
The press release, dated March 5, 2018, announcing the election of Dr. Littman is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Separately, on March 2, 2018, Mr. Stephen W. Sanger, who has served as a director of the Company since 2009, notified the Company of his intention to retire from the Board of Directors at the Annual Meeting of Shareholders in April 2018.
|
Item 9.01 |
Financial Statements and Exhibits. |
EXHIBIT INDEX
|
Exhibit No. |
Description |
|
Press Release of Pfizer Inc. dated March 5, 2018
|
PFIZER INC ExhibitEX-99.1 2 exh991352018docx.htm EXHIBIT 99.1 PFIZER INC. PRESS RELEASE Exhibit Exhibit 99.1For immediate releaseMedia Contact:March 5,…To view the full exhibit click here
